Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Czech Version of the Patient Dignity Inventory: Translation and Validation in Incurable Patients

H. Kisvetrová, D. Školoudík, L. Danielová, K. Langová, R. Váverková, M. Bretšnajdrová, Y. Yamada,

. 2018 ; 55 (2) : 444-450. [pub] 20171109

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't, Validation Study

Grant support
NV16-28628A MZ0 CEP Register

CONTEXT: The Patient Dignity Inventory (PDI) is a valid, reliable screening tool to assess a range of issues that have been reported to affect the sense of dignity in patients with life-limiting conditions. OBJECTIVES: We investigated the item characteristics, factor structure, and reliability of the Czech version of the PDI (PDI-CZ) among cancer and noncancer patients. METHODS: The PDI was translated into the Czech language following state-of-the-art criteria (a five-stage proceeding method for the translation). Two hundred thirty-nine participants completed the study (136 cancer and 103 noncancer patients). Internal consistency, test-retest reliability, and factor analysis were used for validation of the PDI-CZ. RESULTS: A Czech version of the PDI was obtained. The Cronbach's α for PDI-CZ was 0.92. Item 22 (not feeling supported by my health care providers) did not correlate with any other items, and it was skipped for factor analysis processing for this reason. Factor analysis resulted in a four-factor solution, accounting for 56.34% of the overall variance (factor loadings range, 0.37-0.92). The factor labels were as follows: loss of purpose of life; loss of autonomy; loss of confidence; and loss of social support (internal consistencies range, Cronbach's α 0.58-0.90). Test-retest reliability was assessed with 25 patients after two weeks. The resulting range of the Gwet's coefficient, AC1, was between 0.58 and 1.00. CONCLUSION: The results from the study support the reliability of the PDI-CZ and its future use in patients with incurable cancer and noncancer patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028697
003      
CZ-PrNML
005      
20201007082142.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpainsymman.2017.10.008 $2 doi
035    __
$a (PubMed)29128432
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kisvetrová, Helena $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic. Electronic address: helena.kisvetrova@upol.cz.
245    10
$a Czech Version of the Patient Dignity Inventory: Translation and Validation in Incurable Patients / $c H. Kisvetrová, D. Školoudík, L. Danielová, K. Langová, R. Váverková, M. Bretšnajdrová, Y. Yamada,
520    9_
$a CONTEXT: The Patient Dignity Inventory (PDI) is a valid, reliable screening tool to assess a range of issues that have been reported to affect the sense of dignity in patients with life-limiting conditions. OBJECTIVES: We investigated the item characteristics, factor structure, and reliability of the Czech version of the PDI (PDI-CZ) among cancer and noncancer patients. METHODS: The PDI was translated into the Czech language following state-of-the-art criteria (a five-stage proceeding method for the translation). Two hundred thirty-nine participants completed the study (136 cancer and 103 noncancer patients). Internal consistency, test-retest reliability, and factor analysis were used for validation of the PDI-CZ. RESULTS: A Czech version of the PDI was obtained. The Cronbach's α for PDI-CZ was 0.92. Item 22 (not feeling supported by my health care providers) did not correlate with any other items, and it was skipped for factor analysis processing for this reason. Factor analysis resulted in a four-factor solution, accounting for 56.34% of the overall variance (factor loadings range, 0.37-0.92). The factor labels were as follows: loss of purpose of life; loss of autonomy; loss of confidence; and loss of social support (internal consistencies range, Cronbach's α 0.58-0.90). Test-retest reliability was assessed with 25 patients after two weeks. The resulting range of the Gwet's coefficient, AC1, was between 0.58 and 1.00. CONCLUSION: The results from the study support the reliability of the PDI-CZ and its future use in patients with incurable cancer and noncancer patients.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a kritický stav $x psychologie $7 D016638
650    _2
$a faktorová analýza statistická $7 D005163
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory $x diagnóza $x psychologie $7 D009369
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    12
$a uznání $7 D000078682
650    _2
$a překládání $7 D014175
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Školoudík, David $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Danielová, Libuše $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic; Department of Geriatrics, University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Langová, Kateřina $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Váverková, Renáta $7 xx0252460 $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic.
700    1_
$a Bretšnajdrová, Milena $u Department of Geriatrics, University Hospital Olomouc, Olomouc, Czech Republic.
700    1_
$a Yamada, Yukari $u Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic; Department of Healthcare Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
773    0_
$w MED00005093 $t Journal of pain and symptom management $x 1873-6513 $g Roč. 55, č. 2 (2018), s. 444-450
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29128432 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20201007082139 $b ABA008
999    __
$a ok $b bmc $g 1433846 $s 1067157
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 55 $c 2 $d 444-450 $e 20171109 $i 1873-6513 $m Journal of pain and symptom management $n J Pain Symptom Manage $x MED00005093
GRA    __
$a NV16-28628A $p MZ0
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...